首页 | 本学科首页   官方微博 | 高级检索  
     


Tactics targeting circular mRNA biosynthesis
Authors:Xinjie Chen  Chen Wang  Yuan Lu
Affiliation:1. Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing, China

Department of Chemical Engineering, Tsinghua University, Beijing, China;2. Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing, China

Abstract:Faced with the development of mRNA technology in the field of medicine and vaccine, circular mRNA (circmRNA) becomes a strong alternative to mRNA for its circular secondary structure and higher stability. At present, the synthesis of circmRNAs has been realized by ligating linear mRNA precursors and is limited by poor efficiency. To solve this challenge, this study started with ribozyme catalysis and enzymatic reaction to explore different circmRNA biosynthesis strategies. In terms of ribozyme method, by screening different group I intron self-splicing system sequences, the sequence from thymidylate synthase (Td) gene of phage T4 showed the highest ligation efficiency. In terms of enzyme method, with the help of 20-bp homologous arm, T4 Rnl 2 was determined as the ligation method with the highest ligation efficiency. By comparing the two ligation methods, the expression level of circmRNA ligated by T4 Rnl 2 was 86% higher than that ligated by Td ribozyme. Based on these ligation methods, the screening results of internal ribosome entry site (IRES) sequences showed that mud crab dicistrovirus IRES was an IRES sequence with high ribosome binding ability and could be widely used in circmRNAs for efficient and stable translation in mammalian cells. These results should provide positive guidance for the industrial production of circmRNAs and the development of mRNA vaccines. Eventually, circmRNAs could widely function in the field of biomedicine.
Keywords:circular mRNA  enzymatic ligation  internal ribosome entry site  mRNA synthesis  permuted intron–exon
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号